MedPath

XPOVIO

XPOVIO

Approved
DIN Number

02527677

Drug Class

Human

Market Date

Jul 7, 2022

Company
HC

forus therapeutics inc.

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02527677
AIG Number0163741001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
L01XX66 SELINEXOR
Product Specifications
Dosage FormTablet
Route of AdministrationOral
AHFS Classification10:00.00
Health Canada Classification

ACTIVE INGREDIENTS (1)

SELINEXORActive
Strength: 20 MG
Monograph: SELINEXOR

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.